Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Warmed Saline for Vaso-Oclusive Episodes in Sickle Cell Disease
source: The American Academy of Pediatrics
year: 2020
summary/abstract:Investigators from the University of Maryland Medical Center, Baltimore, and Nationwide Children’s Hospital, Columbus, OH, conducted a randomized controlled trial to assess the effectiveness of warmed IV saline administered to children with vaso-occlusive episodes (VOE) and sickle cell disease (SCD). Children 4–21 years with known SCD who required treatment for uncomplicated VOE at Nationwide Children’s Hospital between November 2012 and June 2014 were eligible. VOE was defined as pain in the back, extremities, abdomen, or chest rated as >3 on the Wong-Baker FACES scale. Study patients were randomized to receive either IV saline warmed to 37.5°C (intervention) or at room temperature (22°C–24°C control). Children in both groups received a 20 ml/kg bolus of IV saline, then provided fluid at a maintenance rate.
DOI: 10.1542/gr.44-3-35read more
+myBinderRelated Content
-
Prevention of acute chest syndrome by implementing a standardized process to improve incentive spirometry use in hos...Acute chest syndrome (ACS) is the second...
-
FDA Approves First Targeted Therapy to Treat Patients with Painful Complication of Sickle Cell DiseaseToday, the U.S. Food and Drug Administra...
-
Marijuana use in adults living with sickle cell diseaseIntroduction: Legal access to marijuana,...
-
At 16, She’s a Pioneer in the Fight to Cure Sickle Cell DiseaseHelen Obando, a shy slip of a girl, lay ...
-
Matthew Porteus awarded grant for sickle cell anemia workThe California Institute for Regenerativ...
-
UH BEATS programhttps://www.youtube.com/watch?v=lzvl_tyv...
-
Potential treatment targeting nitric oxide levels, olinciguat, named orphan drug by FDAThe U.S. Food and Drug Administration ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.